Prudential Financial
MRNS

Prudential Financial’s Marinus Pharmaceuticals, Inc MRNS Stock Holding History

Prudential Financial’s Portfolio MRNS Stock Details MRNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-385,250
Closed -$678K – 2814
2024
Q3 		$678K Hold
385,250
– – ﹤0.01% 2084
2024
Q2 		$451K Sell
385,250
-5,180
-1% -$13K ﹤0.01% 2233
2024
Q1 		$3.53M Buy
390,430
+39,600
+11% +$385K 0.01% 1129
2023
Q4 		$3.81M Buy
350,830
+79,550
+29% +$596K 0.01% 1076
2023
Q3 		$2.23M Hold
271,280
– – ﹤0.01% 1301
2023
Q2 		$2.95M Buy
+271,280
New +$2.32M ﹤0.01% 1186

Other funds holding MRNS

BCM
Beryl Capital Management Redondo Beach, California $110M AUM 317.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
OBAM
ODDO BHF Asset Management Paris, France $2.54B AUM 41.83% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Prudential Financial's MRNS Position: Q4 2024 in Review

Prudential Financial sold out of Marinus Pharmaceuticals, Inc (MRNS) in Q4 2024, closing a stake of 385,250 shares — an estimated $678K sold.

Prudential Financial first reported a position in MRNS in Q2 2023 and held it in 6 quarters. The position peaked at $3.81M in Q4 2023. 53 funds tracked by Wall St. Rank hold MRNS as of Q4 2024.

  • Prudential Financial reported no remaining Marinus Pharmaceuticals, Inc position as of Q4 2024 after selling out during the quarter.
  • Prudential Financial sold 385,250 Marinus Pharmaceuticals, Inc shares in Q4 2024, an estimated $678K.
  • Prudential Financial first reported a position in Marinus Pharmaceuticals, Inc in Q2 2023 and held it in 6 quarters.
  • Prudential Financial's Marinus Pharmaceuticals, Inc position peaked at $3.81M in Q4 2023.
  • 53 funds tracked by Wall St. Rank held Marinus Pharmaceuticals, Inc as of Q4 2024.

Based on Prudential Financial's 13F filing for Q4 2024, filed 11 Feb 2025.